Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 237-241 , December 2007

Photodynamic therapy with di-l-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice

  • Andrzej Bugaj, MSc in Pharm, PhD

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello 0-310 Oslo, Norway
    • Corresponding Author InformationCorresponding author at: Os. Jagiellońskie 3 m. 9, 61-224 Poznań, Poland. Tel.: +48 501645004.
    • ,
  • Mateusz Kwitniewski

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello 0-310 Oslo, Norway
    • Department of Molecular Microbiology and Serology, National Salmonella Centre, Medical University of Gdańsk, ul. Do Studzienki 38, 81-519 Gdańsk, Poland
    • ,
  • Vladimir Iani

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello 0-310 Oslo, Norway
    • ,
  • Asta Juzeniene

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello 0-310 Oslo, Norway
    • ,
  • Petras Juzenas

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello 0-310 Oslo, Norway
    • ,
  • Li Wei Ma

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello 0-310 Oslo, Norway
    • ,
  • Johan Moan

      Affiliations

    • Department of Radiation Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello 0-310 Oslo, Norway
    • Institute of Physics, University of Oslo, 0-316 Oslo, Norway

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2006. CA Cancer J Clin. 2006;56:106–130
  2. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15:499–545
  3. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence. Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0, Lyon: IARC Press 2004.
  4. Bown SG, Millson CE. Photodynamic therapy in gastroenterology. Gut. 1997;41:5–7
  5. Webber J, Herman M, Kessel D, Fromm D. Current concepts in gastrointestinal photodynamic therapy. Ann Surg. 1999;230:12–23
  6. Banfi S, Caruso E, Caprioli S, et al. Photodynamic effects of porphyrin and chlorin photosensitizers in human colon adenocarcinoma cells. Bioorg Med Chem. 2004;12:4853–4860
  7. West CML, Moore JV. Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS. Int J Radiat Biol. 1988;54:621–634
  8. Barr H, Tralau CJ, Boulos PB, et al. Selective necrosis in dimethylhydrazine-induced rat colon tumours using phtalocyanine photodynamic therapy. Gastroenterology. 1990;98:1532–1537
  9. Kashtan H, Haddad R, Yossiphov Y, Bar-On S, Skornick Y. Photodynamic therapy of colorectal cancer using a new light source. From in vitro studies to a patient treatment. Dis Colon Rectum. 1996;4:379–383
  10. Barr H, Tralau CJ, Boulos PB, MacRobert AJ, Tilly R, Bown SG. The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem Photobiol. 1987;46:795–800
  11. Regula J, MacRobert AJ, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX—a pilot study. Gut. 1995;36:67–75
  12. Mĺkvy P, Messmann H, Regula J, et al. Photodynamic therapy for gastrointestinal tumours using three photosensitizers—ALA induced PPIX, Photofrin and MTHPC. A pilot study. Neoplasma. 1998;45:157–161
  13. Patrice T, Foultier MT, Yactayo S, et al. Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients. Digest Dis Sci. 1990;35:545–552
  14. Agrez MV, Warren RE, Andersen RE, Laws ER, Ilstrup DM. Hematoporphyrin derivative quantitative uptake in DMH induced murine colorectal carcinoma. J Surg Oncol. 1983;24:173–176
  15. Mĺkvy P, Messmann H, Regula J, et al. Sensitization and photodynamic therapy (PDT) of gastrointestinal tumours with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study. Neoplasma. 1995;42:109–113
  16. Graczyk A, Konarski J. Hematoporphyrin derivatives complex salts and their use in the detection and treatment of neoplasms. European patent no. EP 053 99 60 B1: 1997.
  17. Graczyk A, Janik P. Investigations of therapeutic efficiency of porphyrin amino acid derivatives PP(AA)2Arg2 sensitizers on cell lines, IPA Conference, Nantes, 1998, poster 86.
  18. Bugaj A, Morlière P, Santus R, Haigle J, Dyderski S. Phototoxicity of protoporphyrin IX, diarginine diprotoporphyrinate and N,N-diphenylalanyl protoporphyrin toward human fibroblasts and keratinocytes in vitro; effect of 5-methoxypsoralen. Photochem Photobiol. 2004;80:486–491
  19. Wolford ST, Novicki DL, Kelly B. Comparative skin phototoxicity in mice with two photosensitizing drugs: benzoporphyrin derivative monoacid ring A and porfimer sodium (Photofrin). Fundam Appl Toxicol. 1995;24:52–56
  20. Okamoto Y, Yonemura D, Miyatake K, et al. Tissue retention and adverse reaction after intravenous injection of hematoporphyrin derivatives in dogs. J Vet Med Sci. 2004;66:1599–1601
  21. Juzenas P, Juzeniene A, Kaalhus O, Iani V, Moan J. Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo. Photochem Photobiol Sci. 2002;1:745–748
  22. Peng Q, Warloe T, Moan J, et al. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of Photofrin in human. Cancer Res. 2001;61:5824–5832
  23. McDowell EM, Trump BF. Histological fixative suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med. 1976;100:405–414
  24. Pirożyńska E, Kozłowski W, Graczyk A, Patera J, Kupść-Zajdler M. Effect of photodynamic therapy with PP(Ala)2Arg2 on transplanted tumour in mice, IPA Conference, Nantes 1998, poster 33.
  25. Gomer ChJ, Jester JV, Razum NJ, Szirth BC, Murphree AL. Photodynamic therapy of intraocular tumours examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. Cancer Res. 1985;45:3718–3725
  26. Moan J, Ma L-W, Juzeniene A, et al. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int J Cancer. 2003;103:132–135
  27. de Rosa FS, Lopez RFV, Thomazini JS, Tedesco AC, Lange N, Bentley MVLB. In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PPIX accumulation studies. Pharm Res. 2004;21:2247–2252
  28. Kelty CJ, Brown NJ, Reed MWR, Ackroyd R. The use of 5-aminolaevulinic acid as a photosensitizer in photodynamic therapy and photodiagnosis. Photochem Photobiol Sci. 2002;3:158–168
  29. Kennedy JC, Nadeau P, Petryka ZJ, Pottier RH, Weagle G. Clearance times of porphyrin derivatives from mice as measured by in vivo fluorescence spectroscopy. Photochem Photobiol. 1992;55:729–734
  30. Oleinick NL, Morris RL, Belichenko I. The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci. 2002;1:1–21
  31. Bourré L, Rousset N, Thibaut S, Eléouet S, Lajat Y, Patrice T. PDT effects of m-THPC and ALA, phototoxicity and apoptosis. Apoptosis. 2002;7:221–230
  32. Matroule J-Y, Carthy CM, Granville DJ, Jolois O, Hunt DWC, Piette J. Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene. 2001;20:4070–4084

PII: S1572-1000(07)00096-8

doi: 10.1016/j.pdpdt.2007.08.001

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 4 , Pages 237-241 , December 2007

Article Tools

* Image Usage & Resolution